60526-81-0

Basic information

• Product Name: 1-(1 1-DIMETHYLHEPTYL)-3 5-DIMETHOXYBEN&
• Synonyms: 1-(1 1-DIMETHYLHEPTYL)-3 5-DIMETHOXYBEN&;5-(1,1-dimethylheptyl)-1,3-dimethoxybenzene;5-(1,1-dimethylheptyl)3,5-dimethoxybenzene;3-(1,1-DIMETHYL-HEPTYL)-5-METHOXYANISOLE;1-(1,1-Dimethylheptyl)-3,5-dimethoxybenzene;Einecs 262-280-2;1,3-DiMethoxy-5-(2-Methyloctan-2-yl)benzene
• CAS NO: 60526-81-0
• Molecular Formula: C₁₇H₂₈O₂
• Molecular Weight: 264.40302
• EINECS: 262-280-2
• Product Categories: Ethers;Organic Building Blocks;Oxygen Compounds;Building Blocks;C15 to C19;Chemical Synthesis;Organic Building Blocks;Oxygen Compounds
• Mol File: 60526-81-0.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 122 °C0.5 mm Hg(lit.)
• Flash Point: >230 °F
• Appearance: /
• Density: 0.943 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.000108mmHg at 25°C
• Refractive Index: n20/D 1.500(lit.)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-(1 1-DIMETHYLHEPTYL)-3 5-DIMETHOXYBEN&(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(1 1-DIMETHYLHEPTYL)-3 5-DIMETHOXYBEN&(60526-81-0)
• EPA Substance Registry System: 1-(1 1-DIMETHYLHEPTYL)-3 5-DIMETHOXYBEN&(60526-81-0)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 60526-81-0(Hazardous Substances Data)

Usage

General Description

1-(1 1-DIMETHYLHEPTYL)-3 5-DIMETHOXYBEN& is a synthetic cannabinoid that acts as a potent agonist at the CB1 and CB2 receptors, producing a variety of physiological and psychoactive effects. It is a derivative of the naturally occurring compound THC, found in cannabis, and is known to have a high affinity for the cannabinoid receptors. The compound has been reported as having strong psychoactive and hallucinogenic properties, with effects similar to those of cannabis, but potentially more potent. As with other cannabinoids, 1-(1 1-DIMETHYLHEPTYL)-3 5-DIMETHOXYBEN& has the potential for abuse and dependence, and can cause adverse effects on mental and physical health. Its use and distribution are subject to legal restrictions in many countries.

InChI:InChI=1/C17H28O2/c1-6-7-8-9-10-17(2,3)14-11-15(18-4)13-16(12-14)19-5/h11-13H,6-10H2,1-5H3

Upstream product

• 866398-16-5 trifluoromethanesulfonic acid 4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl ester 
• 628-44-4 2-methyl-2-octanol 
• 56469-10-4 5-(1',1'-dimethyl-n-heptyl)-1,3-dihydroxybenzene 
• 77-78-1 dimethyl sulfate 
• 120078-30-0 2-(3,5-dimethoxyphenyl)-2-methylpropanal 
• 22972-63-0 α,α-dimethyl-3,5-dimethoxyphenylacetonitrile 
• 60526-75-2 4-(1',1'-dimethylheptyl)-2,6-dimethoxyphenyl diethylphosphate 
• 775352-38-0 (+/-)-3-hydroxy-2-methyl-2-(3.5-dimethoxy-phenyl)-octane 
• 21369-64-2 n-hexyllithium 
• 39151-19-4 1-(3,5-dimethoxyphenyl)ethan-1-one 
• 39192-51-3 1-(3,5-dimethoxyphenyl)heptan-1-one 
• 155586-39-3 (3,5-dimethoxyphenyl)-N-methoxy-N-methylcarboxamide 
• 17213-57-9 3,5-dimethoxybenzoyl chloride 
• 1132-21-4 3,5-dimethoxybenzoic acid 

Downstream Products

• 468083-92-3 O 1962 
• 468083-98-9 O 2072 
• 866398-19-8 trifluoromethanesulfonic acid 3-(1,1-dimethylheptyl)-5-methoxyphenyl ester 
• 866398-11-0 (1R,3R,4R)-3-[4-(1,1-dimethylheptyl)-2-methoxyphenyl]-4-(3-hydroxypropyl)cyclohexanol 
• 866398-05-2 (1R,4R,5R,8S)-4-[4-(1,1-dimethylheptyl)-2-methoxyphenyl]-8-methoxymethoxybicyclo[3.3.1]non-3-en-2-one 
• 866398-09-6 3-{(7R,8R)-7-[4-(1,1-dimethylheptyl)-2-methoxyphenyl]-1,4-dioxaspiro[4,5]dec-8-yl}propan-1-ol 
• 866398-07-4 (7R,8R)-7-[4-(1,1-dimethylheptyl)-2-methoxyphenyl]-8-(2-[1,3]dioxolan-2-ylethyl)-1,4-dioxaspiro[4,5]decane 
• 83002-04-4 CP 55,940 
• 866398-21-2 1-(1,1-dimethylheptyl)-3-methoxybenzene 
• 181764-33-0 1-bromo-4-(1,1-dimethylheptyl)-2-methoxybenzene 
• 1309372-84-6 HU 910 
• 1309372-88-0 HU 914 

Relevant articles and documents

METHODS AND COMPOSITIONS RELATING TO ULTRAPURE 5-(1,1-DIMETHYLHEPTYL)-RESORCINOL

The invention provides methods and compositions relating to an ultrapure formulation of 5-(1,1-dimethylheptyl)-resorcinol (ultrapure DMHR). The invention features methods for making ultrapure DMHR, including methods that minimize the production of unwanted side products (e.g., the production of homologous alkyl-chain impurities). The invention also features methods of making cannabinoids, such as (6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyl-2-octanyl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromene-9-carboxylic acid (ajulemic acid), using ultrapure DMHR, including methods that minimize the production of unwanted side products (e.g., the production of homologous alkyl-chain impurities) in the resulting cannabinoid preparation.

Expedient synthesis of potent cannabinoid receptor agonist (-)-CP55,940

(Chemical Equation Presented) A stereocontrolled synthesis of (-)-CP55,940, a potent cannabinoid receptor agonist, has been attained using a novel aldolization/retroaldolization interconversion strategy, in which a temporarily generated chiral aldol motif plays essential roles.

Synthesis of functionalized cannabinoids

An effective synthesis of tricyclic, nonclassical cannabinoids has been developed on the basis of a cation-olefin cyclization that forms the two nonaromatic rings with the desired stereochemistry in a single step.